Pediatric Drugs

Papers
(The TQCC of Pediatric Drugs is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives69
Drug Treatment of Heart Failure in Children: Gaps and Opportunities43
Comment on: “The Effect of Alfentanil on Emergence Delirium Following General Anesthesia in Children: A Randomized Clinical Trial”38
A Narrative Review of Pain in Pediatric Oncology: The Opioid Option for Procedural and Surgical Pain30
Developing CAR T-Cell Therapies for Pediatric Solid Tumors29
Impact of Antiseizure Medications on Appetite and Weight in Children28
Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department22
Pain Management in Children: NSAID Use in the Perioperative and Emergency Department Settings22
Randomized Clinical Trial of Metoclopramide as Prophylaxis of Gastroesophageal Reflux Disease in Preterm Infants21
A Multi-Center Evaluation of the Pharmacokinetics and Safety of Intravenous Ibuprofen in Infants 1–6 Months of Age21
Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis20
Safety of Ferric Carboxymaltose in Children: Report of a Case Series from Greece and Review of the Literature20
Safety of Quinolones in Children: A Systematic Review and Meta-Analysis19
Common Selfcare Indications of Pain Medications in Children19
Effectiveness and Safety of Ustekinumab for Pediatric Inflammatory Bowel Disease: A Systematic Review19
Implications of Evolving Disease Classification for Drug Approval in Juvenile Idiopathic Arthritis19
Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)18
Pharmacotherapy for Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Childhood Cancer Survivors18
Authors’ Reply to Sethuraman’s comment on “The Effect of Alfentanil on Emergence Delirium Following General Anesthesia in Children: A Randomized Clinical Trial”18
Treatment Options for Alopecia Areata in Children and Adolescents16
Use of Furosemide and Chlorothiazide Combination Continuous Infusion in Furosemide-Refractory Patients in the Pediatric Intensive Care Unit: A Retrospective Cohort Study15
Prucalopride for Treatment of Upper Gastrointestinal Symptoms in Children14
Pediatric Drugs, Accelerated Approval, and Prospects for Reform14
Mechanism-Based Pharmacological Treatment for Chronic Non-cancer Pain in Adolescents: Current Approaches and Future Directions13
Oral Ibuprofen for the Treatment of PDA in Preterm Neonates: Urgent Need for a Safer Alternative to Hyperosmolar Formulations11
Interventions for the Management of Pain and Sedation in Newborns Undergoing Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy: A Systematic Review11
Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies11
Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey10
Drug–Drug Interactions Involving High-Alert Medications that Lead to Interaction-Associated Symptoms in Pediatric Intensive Care Patients: A Retrospective Study10
Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update10
Alirocumab: Pediatric First Approval10
Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab10
Golimumab in Children with Chronic Recurrent Multifocal Osteomyelitis: A Case Series and Review of the Literature10
Existing and Emerging Targeted Therapies in Juvenile Psoriatic Arthritis: Challenges and Unmet Needs10
Pitolisant: Pediatric First Approval9
An Update of Pharmacological Management in Children with Functional Constipation9
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis9
Pharmacokinetics in Critically Ill Children with Acute Kidney Injury9
Pharmacokinetics of l-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension8
Treatment Options in Pediatric Behçet’s Disease8
Evaluating and Mitigating Risk of Acute Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam in Children8
Correction to: Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis8
Hemodynamic Quality Improvement Bundle to Reduce the Use of Inotropes in Extreme Preterm Neonates8
A Mixed-Methods Analysis of Medication Safety Incidents Reported in Neonatal and Children’s Intensive Care8
Immunosuppression Regimens for Intestinal Transplantation in Children8
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations8
Correction: Enteral and Parenteral Treatment with Caffeine for Preterm Infants in the Delivery Room: A Randomised Trial8
Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates8
Perforated Appendicitis in Children: Management, Microbiology, and Antibiotic Stewardship7
Population Pharmacokinetics of Moxifloxacin in Children7
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group7
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia7
Innovations in Clinical Development in Rare Diseases of Children and Adults: Small Populations and/or Small Patients7
Practical Questions About Rescue Medications for Acute Treatment of Seizure Clusters in Children and Adolescents with Epilepsy in the USA: Expanding Treatment Options to Address Unmet Needs7
Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature7
Intercepting Medication Errors in Pediatric In-patients Using a Prescription Pre-audit Intelligent Decision System: A Single-center Study7
Paradoxical Psoriasis in Children Receiving Anti-TNFα Treatment for Inflammatory/autoimmune Disease7
Use of Computerized Physician Order Entry with Clinical Decision Support to Prevent Dose Errors in Pediatric Medication Orders: A Systematic Review6
Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors6
Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention6
Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Pediatric Patients During Extracorporeal Membrane Oxygenation: A Systematic Review6
Bosutinib: Pediatric First Approval6
Machine Learning: A Potential Therapeutic Tool to Facilitate Neonatal Therapeutic Decision Making6
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review6
Preventing Recurrence of Crohn’s Disease Post-Ileocaecal Surgery in Paediatric Patients: A Therapy Guide Based on Systematic Review of the Evidence6
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population6
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis6
Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary6
Targeted Treatments for Myasthenia Gravis in Children and Adolescents6
0.047343015670776